Drug Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
LDOS | A | Leidos Holdings, Inc. | 1.86 | |
MNMD | B | Mind Medicine (MindMed) Inc. | 0.63 | |
ITCI | B | Intra-Cellular Therapies Inc. | -5.91 | |
BLTE | C | Belite Bio, Inc. | -0.93 | |
CDXS | C | Codexis, Inc. | -1.98 | |
PTN | C | Palatin Technologies, Inc. | -1.44 | |
SWTX | D | SpringWorks Therapeutics, Inc. | -7.63 | |
CERT | D | Certara, Inc. | -7.42 | |
ONCT | D | Oncternal Therapeutics, Inc. | 0.41 | |
RIGL | D | Rigel Pharmaceuticals, Inc. | -16.61 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Semiconductor Equipment & Materials
Related Stock Lists:
Biopharmaceutical
Cancer
Chemical Compounds
Clinical Development
Dysfunction
Enzymes
Life Sciences
Pharmacy
Active Pharmaceutical Ingredients
Adenosine
Aging Associated Diseases
Alcohol
Alzheimer's Disease
Asthma
Autism
Autism Spectrum Disorder
Autoimmune Disease
Biofuel
Biomass
Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PSIL | F | AdvisorShares Psychedelics ETF | 21.23 | |
XPH | D | SPDR S&P Pharmaceuticals ETF | 5.22 | |
BBP | C | BioShares Biotechnology Products Fund | 4.6 | |
SHLD | A | Global X Defense Tech ETF | 4.52 | |
IBRN | D | iShares Neuroscience and Healthcare ETF | 4.51 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Semiconductor Equipment & Materials
Related Stock Lists:
Biopharmaceutical
Cancer
Chemical Compounds
Clinical Development
Dysfunction
Enzymes
Life Sciences
Pharmacy
Active Pharmaceutical Ingredients
Adenosine
Aging Associated Diseases
Alcohol
Alzheimer's Disease
Asthma
Autism
Autism Spectrum Disorder
Autoimmune Disease
Biofuel
Biomass
Biotechnology
- Drug Development
Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles